Alnylam Pharmaceuticals (ALNY) Enterprise Value Growth (5y) (2014 - 2026)
Alnylam Pharmaceuticals (ALNY) Enterprise Value Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.13% |
| Dec 31, 2025 | -9.68% |
| Sep 30, 2025 | 3.45% |
| Jun 30, 2025 | -10.79% |
| Mar 31, 2025 | -39.00% |
| Dec 31, 2024 | -11.63% |
| Sep 30, 2024 | 8.43% |
| Jun 30, 2024 | -6.30% |
| Mar 31, 2024 | 11.05% |
| Dec 31, 2023 | -41.78% |
| Sep 30, 2023 | 3.11% |
| Jun 30, 2023 | 13.75% |
| Mar 31, 2023 | 14.94% |
| Dec 31, 2022 | -5.07% |
| Sep 30, 2022 | -2.94% |
| Jun 30, 2022 | 8.06% |
| Mar 31, 2022 | -31.71% |
| Dec 31, 2021 | -7.50% |
| Sep 30, 2021 | -44.98% |
| Jun 30, 2021 | -22.93% |